Loading organizations...
Colorescience develops all-mineral clinical skincare solutions, emphasizing protection from environmental aggressors. Their product line includes mineral sunscreens, treatments, and cosmetics, formulated to deliver immediate aesthetic benefits while promoting long-term skin health. The company utilizes advanced mineral technology to create protective and corrective formulations that address various skin concerns with a focus on non-chemical approaches.
Colorescience was founded in 2001 by Diane Ranger, a pioneer in the beauty industry. Ranger, who originated the concept of mineral makeup in 1977, established Colorescience with the insight that makeup could serve as an extension of skincare, offering both coverage and therapeutic benefits. Her background in innovating within specialty body care led to the development of products like Sunforgettable, the first-ever powder sunscreen, blending protection with cosmetic application.
The company’s products are utilized by a broad base of consumers, often recommended by dermatologists and aestheticians seeking effective yet gentle skincare. Colorescience aims to redefine healthy beauty by integrating high-performance minerals with preventative and corrective ingredients. Its long-term vision centers on empowering individuals with advanced, non-toxic skincare options that provide comprehensive protection and foster optimal skin vitality.
Colorescience has raised $76.5M across 5 funding rounds.
Colorescience has raised $76.5M in total across 5 funding rounds.
Colorescience is a skincare company specializing in mineral-based sun protection and clinical skincare products, founded in 2000 and headquartered in Carlsbad, California.[3] It develops innovative, physician-recommended formulas like sunscreens, treatments, and serums that protect against UVA/UVB rays, blue light, infrared radiation, pollution, and free radicals while addressing skin concerns such as aging and pigmentation.[1][2][3] The company serves consumers seeking clean, reef-safe, chemical-free skincare—particularly those with sensitive skin—through licensed physicians and direct online sales, solving the problem of inadequate, aesthetically unappealing sun protection by offering elegant, wearable formats like brush-on powders with SPF 50 and water resistance up to 80 minutes.[1][4][5] With $76.24M raised and patented technologies, Colorescience demonstrates steady growth, including recent launches of seven new EnviroScreen® products.[1][3]
Colorescience was founded in 2000 in Carlsbad, California, emerging from a commitment to science-backed, all-mineral sun protection amid rising awareness of chemical sunscreen limitations.[3][5] While specific founders are not detailed in available sources, the company originated as a pioneering professional skincare brand dedicated to preventing skin damage before it starts, using cutting-edge innovation with the best ingredients for women of all ages and skin types.[1][8] Early traction came from its proprietary mineral formulations trusted by physicians, evolving into a focus on multifunctional protection; pivotal moments include patenting EnviroScreen® Technology—a triple-coated mineral active that reduces free radical formation by 65% under UV and pollution stress—and publishing study results in *The Journal of Cosmetic Dermatology* validating its efficacy against environmental aggressors.[2][4][6] This built a reputation for clinically-tested products like the Skin Cancer Foundation-sealed powder sunscreens.[4]
Colorescience stands out in the skincare market through patented, science-driven innovations:
Colorescience rides the wave of advanced skincare technology, blending materials science (patented mineral coatings) with dermatological research to address escalating environmental threats like blue light from devices and urban pollution—trends amplified by increased screen time and climate change.[2][4][6] Its timing aligns with consumer demand for clean beauty: post-2020 shifts toward reef-safe, sensitive-skin-friendly products amid chemical sunscreen bans and sustainability mandates.[5] Market forces favoring it include a booming $150B+ global skincare sector, where mineral SPF grows at 8-10% CAGR due to health-conscious millennials/Gen Z and physician endorsements; Colorescience influences the ecosystem by setting benchmarks via peer-reviewed studies and innovations adopted by dermatologists, pushing competitors like ZO Skin Health toward multifunctional protection.[3][4] This positions it as a leader in "health-first beauty," humanizing sun care through wearable science.
Colorescience is poised for expansion with its EnviroScreen® edge, likely launching more versatile formats amid rising demand for AI-personalized skincare and eco-regulations. Trends like blue light blockers and antioxidant-infused minerals will propel growth, potentially through partnerships with tele-dermatology or retail scaling beyond physicians. Its influence may evolve toward global dominance in preventive skincare tech, sustaining momentum from $76M funding and recent product drops—reinforcing its role as a bold innovator in mineral sun defense.[1][3]
Colorescience has raised $76.5M in total across 5 funding rounds.
Colorescience's investors include Parag Shah, Adele C. Oliva, Greenspring Associates, HealthCare Ventures, Montreux Equity Partners, Bridge Bank, Longwood Fund, 5AM Ventures, Avalon Ventures, Bain Capital Life Sciences, Domain Associates, OrbiMed.
Colorescience has raised $76.5M across 5 funding rounds. Most recently, it raised $30.0M Debt in September 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 14, 2020 | $30.0M Debt | Parag Shah | |
| Aug 2, 2017 | $15.0M Series C | Adele C. Oliva | Greenspring Associates, HealthCare Ventures, Montreux Equity Partners |
| Feb 18, 2016 | $6.5M Debt | Bridge Bank | |
| Sep 1, 2014 | $15.0M Series B | Longwood Fund | 5AM Ventures, Avalon Ventures, Bain Capital Life Sciences, Domain Associates, OrbiMed, Osage University Partners, Pivotal bioVenture Partners, RiverVest, Heather Preston, Hale BioPharma Ventures, HealthCare Ventures, Split Rock Partners |
| Jun 12, 2013 | $10.0M Series A | Howard Palefsky, Josh Baltzell |